Found: 7
Select item for more details and to access through your institution.
49. Inhibition of Acid Ceramidase Expression by Small Interfering RNA Sensitize Human Prostae Cancer Cells to Apoptin Induced Cell Death.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S21, doi. 10.1016/j.ymthe.2006.08.063
- By:
- Publication type:
- Article
Bystander Effect Contributes to the Antitumor Efficacy of CaSm Antisense Gene Therapy in a Preclinical Model of Advanced Pancreatic Cancer.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 2, p. 357, doi. 10.1016/j.ymthe.2005.06.485
- By:
- Publication type:
- Article
1058. Novel Prostate-Specific Vector Regulation System Incorporating a Probasin-Based Promoter, Tet-Regulated Transcriptional Silencer Protein, and a Positive Feedback Loop
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Establishing a Murine Pancreatic Cancer CaSm Model: Up-regulation of CaSm Is Required for the Transformed Phenotype of Murine Pancreatic Adenocarcinoma
- Published in:
- Molecular Therapy, 2005, v. 11, n. 3, p. 363, doi. 10.1016/j.ymthe.2004.09.023
- By:
- Publication type:
- Article
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 12, doi. 10.1038/sj.cgt.7700746
- By:
- Publication type:
- Article
Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 11, p. 814, doi. 10.1038/sj.cgt.7700651
- By:
- Publication type:
- Article
Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 4, p. 330, doi. 10.1038/sj.cgt.7700576
- By:
- Publication type:
- Article